Abstract:Background: The World Health Organization (WHO) reported that cardiovascular diseases (CVDs) are the leading cause of death worldwide. CVDs are chronic, with complex progression patterns involving episodes of comorbidities and multimorbidities. When dealing with chronic diseases, physicians often adopt a "watchful waiting" strategy, and actions are postponed until information is available. Population-level transition probabilities and progression patterns can be revealed by applying time-variant stochastic modeling methods to longitudinal patient data from cohort studies. Inputs from CVD practitioners indicate that tools to generate and visualize cohort transition patterns have many impactful clinical applications. The resultant computational model can be embedded in digital decision support tools for clinicians. However, to date, no study has attempted to accomplish this for CVDs. Objective: This study aims to apply advanced stochastic modeling methods to uncover the transition probabilities and progression patterns from longitudinal episodic data of patient cohorts with CVD and thereafter use the computational model to build a digital clinical cohort analytics artifact demonstrating the actionability of such models. Methods: Our data were sourced from 9 epidemiological cohort studies by the National Heart Lung and Blood Institute and comprised chronological records of 1274 patients associated with 4839 CVD episodes across 16 years. We then used the continuous-time Markov chain method to develop our model, which offers a robust approach to time-variant transitions between disease states in chronic diseases. Results: Our study presents time-variant transition probabilities of CVD state changes, revealing patterns of CVD progression against time. We found that the transition from myocardial infarction (MI) to stroke has the fastest transition rate (mean transition time 3, SD 0 days, because only 1 patient had a MI-to-stroke transition in the dataset), and the transition from MI to angina is the slowest (mean transition time 1457, SD 1449 days). Congestive heart failure is the most probable first episode (371/840, 44.2%), followed by stroke (216/840, 25.7%). The resultant artifact is actionable as it can act as an eHealth cohort analytics tool, helping physicians gain insights into treatment and intervention strategies. Through expert panel interviews and surveys, we found 9 application use cases of our model. Conclusions: Past research does not provide actionable cohort-level decision support tools based on a comprehensive, 10-state, continuous-time Markov chain model to unveil complex CVD progression patterns from real-world patient data and support clinical decision-making. This paper aims to address this crucial limitation. Our stochastic model–embedded artifact can help clinicians in efficient disease monitoring and intervention decisions, guided by objective data-driven insights from real patient data. Furthermore, the proposed model can unveil progression patterns of any chronic disease of interest by inputting only 3 data elements: a synthetic patient identifier, episode name, and episode time in days from a baseline date.

Identifying Critical State of Complex Diseases by Single-Sample-Based Hidden Markov Model

Characterizing and Differentiating Brain State Dynamics Via Hidden Markov Models

Uncovering the Pre-Deterioration State during Disease Progression Based on Sample-Specific Causality Network Entropy (SCNE)

Gene expression ranking change based single sample pre-disease state detection

A Finite Mixture Hidden Markov Model for Intermittently Observed Disease Process with Heterogeneity and Partially Known Disease Type

A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data

Learning transition times in event sequences: the Event-Based Hidden Markov Model of disease progression

CPMI: comprehensive neighborhood-based perturbed mutual information for identifying critical states of complex biological processes

A Multi-state Non-Markov Framework to Estimate Progression of Chronic Disease

Detection for disease tipping points by landscape dynamic network biomarkers

Modeling Disease Progression Trajectories from Longitudinal Observational Data

Modeling sepsis progression using hidden Markov models

DPVis: Visual Analytics With Hidden Markov Models for Disease Progression Pathways

MIWE: detecting the critical states of complex biological systems by the mutual information weighted entropy

Development of a Cohort Analytics Tool for Monitoring Progression Patterns in Cardiovascular Diseases: Advanced Stochastic Modeling Approach

HiDDEN: a machine learning method for detection of disease-relevant populations in case-control single-cell transcriptomics data

Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis

Individualized survival predictions using state space model with longitudinal and survival data

Detect the early-warning signals of diseases based on signaling pathway perturbations on a single sample

Joint Dynamic Models and Statistical Inference for Recurrent Competing Risks, Longitudinal Marker, and Health Status

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers